Naphthyridine integrase inhibitors

Details Naphthyridine integrase inhibitors Naphthyridine integrase inhibitors

2004-05-12

2010-10-12

Morris, Patricia L (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S003000

Reexamination Certificate

active

07812016

ABSTRACT:
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.

REFERENCES:
patent: 5466697 (1995-11-01), Wilhelm et al.
patent: 7148237 (2006-12-01), Fuji et al.
patent: WO 02/30426 (2002-04-01), None
patent: WO 02/30930 (2002-04-01), None
patent: WO 02/30931 (2002-04-01), None
patent: WO 02/36734 (2002-05-01), None
patent: WO 02/055079 (2002-07-01), None
patent: WO 02/070486 (2002-09-01), None
Montgomery et al., “1-B-D-Arabinofuranosyl, etc.,” J. Med. Chem., 1982, 25, 96-98.
Siddiqui et al., “3-Deaza- and, etc.,” J. Med. Chem., 1995, 38, 1035-1038.
Paeshuyse et al., “A Novel, Highly Selective, etc.,” J of Virology, Jan. 2006, 80(1), 149-160.

Affiliated with

Also associated with

Rating

Naphthyridine integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Naphthyridine integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthyridine integrase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4189713